Sign in to view content

A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema

Bobeck S Modjtahedi, MD

Video
Published 2018

Related

Deferred Compensation? Tax Cuts and the Jobs Act What You Need to Know
Robert C. Wang, MD, FASRS
Updates from the Field
2018
Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA
Sunil Srivastava, MD
Annual Meeting Talks
2021
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022

Category: Diabetic Retinopathy

See more